Trial intelligence / Profile preview

Spiriva in Early Stage COPD

NCT01072396Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Feb 2010
Primary completion
Nov 2011
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Feb 2010; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01072396.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01072396.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call